FDA approval of new gene therapy to treat Duchenne muscular dystrophy grants hope to 4-year-old SoCal boy

A first-of-its-kind gene therapy was approved to treat Duchenne muscular dystrophy, a devastating condition affecting 1 out of 3,500 to 5,000 boys.

Related Keywords

Los Angeles ,California ,United States ,Sacramento ,Thomas Kargar ,Leigh Maria Ramos Platt ,Zac Kargar ,Nicole Orellana ,Children Hospital Los Angeles Neuromuscular Program , ,Duchenne Muscular Dystrophy ,Elevidys ,Gene Therapy ,Fda ,Condition ,Boys ,Health ,Revolutionary ,Medical ,Medical Treatment ,Hild Patient ,